Molecule intelOpportunity: Moderate0

000 Units

5 brands · 5 companies · product forms

Opportunity snapshot

Launch attractiveness
39
Market saturation
13
Price room
72
Regulatory risk
0
5
brands
5
companies
Rs 84.47
median price
6
price points
3.9x
price spread
90
confidence %

Who competes here

Top companies by brand count · leader share 20%

Price room

Across observed sources and strengths
CheapestRs 35.32
MedianRs 84.47
Most expensiveRs 137.82
Spread3.9×
Sources: DRAP-official

max/min price ratio 3.90x across 6 trusted points (Rs 35.32-137.82). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 5 live products for 000 Units — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(12) + 25% price-variation(72) + 20% low-competition(87) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

5 canonical companies and 5 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.90x across 6 trusted points (Rs 35.32-137.82). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.